Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
February 23, 2026
Indian College of Hematology (ICH)& Indian Council of Medical Research (ICMR) Joint Consensus Document on Management and Control of Sickle Cell Disease in India
Rabindra Kumar Jena, Manoranjan Mahapatra, Tuphan Kanti Dolai, et al.
Cancer Chemotherapy and Pharmacology
|
April 24, 2023
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
Ankit Patel, Niraj Bhatt, S S Prakash, et al.
Cancers
|
February 15, 2022
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study
Josée M Zijlstra, George Follows, Rene-Olivier Casasnovas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 26, 2022
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study
Michael Schuster, Josée Zijlstra, Rene-Olivier Casasnovas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 8, 2021
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes
Rene-Olivier Casasnovas, George Follows, Josee M Zijlstra, et al.
Journal of Hematology & Oncology
|
July 17, 2021
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study
Marie Maerevoet, Josee M Zijlstra, George Follows, et al.
Future Oncology (London, England)
|
February 2, 2021
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma
Jatin Shah, Sharon Shacham, Michael Kauffman, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
August 14, 2023
IMPETUS Stroke: Assessment of hospital infrastructure and workflow for implementation of uniform stroke care pathway in India
Manish Salunkhe, Partha Haldar, Rohit Bhatia, et al.
Annals of Indian Academy of Neurology
|
March 28, 2022
Impact of the COVID-19 Pandemic on the Frequency, Clinical Spectrum and Outcomes of Pediatric Guillain-Barré Syndrome in India: A Multicentric Ambispective Cohort Study
Divyani Garg, Rajinder K Dhamija, Aditya Choudhary, et al.
Annals of Indian Academy of Neurology
|
March 13, 2023
Impact of COVID-19 on Guillain-Barre Syndrome in India: A Multicenter Ambispective Cohort Study
Yareeda Sireesha, Ritu Shree, Madhu Nagappa, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
February 23, 2026
Indian College of Hematology (ICH)& Indian Council of Medical Research (ICMR) Joint Consensus Document on Management and Control of Sickle Cell Disease in India
Rabindra Kumar Jena, Manoranjan Mahapatra, Tuphan Kanti Dolai, et al.
Cancer Chemotherapy and Pharmacology
|
April 24, 2023
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
Ankit Patel, Niraj Bhatt, S S Prakash, et al.
Cancers
|
February 15, 2022
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study
Josée M Zijlstra, George Follows, Rene-Olivier Casasnovas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 26, 2022
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study
Michael Schuster, Josée Zijlstra, Rene-Olivier Casasnovas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 8, 2021
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes
Rene-Olivier Casasnovas, George Follows, Josee M Zijlstra, et al.
Journal of Hematology & Oncology
|
July 17, 2021
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study
Marie Maerevoet, Josee M Zijlstra, George Follows, et al.
Future Oncology (London, England)
|
February 2, 2021
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma
Jatin Shah, Sharon Shacham, Michael Kauffman, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
August 14, 2023
IMPETUS Stroke: Assessment of hospital infrastructure and workflow for implementation of uniform stroke care pathway in India
Manish Salunkhe, Partha Haldar, Rohit Bhatia, et al.
Annals of Indian Academy of Neurology
|
March 28, 2022
Impact of the COVID-19 Pandemic on the Frequency, Clinical Spectrum and Outcomes of Pediatric Guillain-Barré Syndrome in India: A Multicentric Ambispective Cohort Study
Divyani Garg, Rajinder K Dhamija, Aditya Choudhary, et al.
Annals of Indian Academy of Neurology
|
March 13, 2023
Impact of COVID-19 on Guillain-Barre Syndrome in India: A Multicenter Ambispective Cohort Study
Yareeda Sireesha, Ritu Shree, Madhu Nagappa, et al.
Page
of 6